Global CRISPR Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global CRISPR market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China CRISPR market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technology that allows scientists to precisely modify DNA sequences within cells. It originated from the immune system of bacteria, where it acts as a defense mechanism against viruses. The CRISPR system works in conjunction with an enzyme called Cas9, which acts as molecular scissors that can cut DNA at specific locations. By guiding the Cas9 enzyme to the desired location on the DNA using a small RNA molecule, scientists can introduce changes to the genetic code, such as deleting, replacing, or adding specific genes. CRISPR has opened up new possibilities in scientific research, medicine, agriculture, and biotechnology, as it enables targeted modifications to the genome with greater ease and efficiency than previous methods. The potential applications of CRISPR are vast, ranging from treating genetic diseases and cancer to improving crop yield and developing new therapies. However, the technology also raises ethical and safety considerations, and its use is subject to strict regulations to ensure responsible and ethical implementation.
The major global suppliers of CRISPR include Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia, Origene Technologies, New England Biolabs, Synthego Corporation, Toolgen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRISPR. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRISPR market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRISPR market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRISPR industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRISPR Include:
Thermo Fisher Scientific
Merck KGaA
GenScript
Integrated DNA Technologies (IDT)
Horizon Discovery Group
Agilent Technologies
Cellecta
GeneCopoeia
Origene Technologies
New England Biolabs
Synthego Corporation
Toolgen
CRISPR Product Segment Include:
CRISPR Enzymes
CRISPR Libraries
CRISPR Kits
Others
CRISPR Product Application Include:
Genome Editing
Disease Modeling
Biotechnology and Agriculture
Therapeutic
Infectious Disease Research
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRISPR Industry PESTEL Analysis
Chapter 3: Global CRISPR Industry Porter's Five Forces Analysis
Chapter 4: Global CRISPR Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRISPR Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRISPR Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRISPR Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global CRISPR market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China CRISPR market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technology that allows scientists to precisely modify DNA sequences within cells. It originated from the immune system of bacteria, where it acts as a defense mechanism against viruses. The CRISPR system works in conjunction with an enzyme called Cas9, which acts as molecular scissors that can cut DNA at specific locations. By guiding the Cas9 enzyme to the desired location on the DNA using a small RNA molecule, scientists can introduce changes to the genetic code, such as deleting, replacing, or adding specific genes. CRISPR has opened up new possibilities in scientific research, medicine, agriculture, and biotechnology, as it enables targeted modifications to the genome with greater ease and efficiency than previous methods. The potential applications of CRISPR are vast, ranging from treating genetic diseases and cancer to improving crop yield and developing new therapies. However, the technology also raises ethical and safety considerations, and its use is subject to strict regulations to ensure responsible and ethical implementation.
The major global suppliers of CRISPR include Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia, Origene Technologies, New England Biolabs, Synthego Corporation, Toolgen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRISPR. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRISPR market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRISPR market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRISPR industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRISPR Include:
Thermo Fisher Scientific
Merck KGaA
GenScript
Integrated DNA Technologies (IDT)
Horizon Discovery Group
Agilent Technologies
Cellecta
GeneCopoeia
Origene Technologies
New England Biolabs
Synthego Corporation
Toolgen
CRISPR Product Segment Include:
CRISPR Enzymes
CRISPR Libraries
CRISPR Kits
Others
CRISPR Product Application Include:
Genome Editing
Disease Modeling
Biotechnology and Agriculture
Therapeutic
Infectious Disease Research
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRISPR Industry PESTEL Analysis
Chapter 3: Global CRISPR Industry Porter's Five Forces Analysis
Chapter 4: Global CRISPR Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRISPR Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRISPR Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRISPR Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 CRISPR Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CRISPR Product by Type
- 1.2.1 CRISPR Enzymes
- 1.2.2 CRISPR Libraries
- 1.2.3 CRISPR Kits
- 1.2.4 Others
- 1.3 CRISPR Product by Application
- 1.3.1 Genome Editing
- 1.3.2 Disease Modeling
- 1.3.3 Biotechnology and Agriculture
- 1.3.4 Therapeutic
- 1.3.5 Infectious Disease Research
- 1.4 Global CRISPR Market Size Analysis (2020-2032)
- 1.5 CRISPR Market Development Status and Trends
- 1.5.1 CRISPR Industry Development Status Analysis
- 1.5.2 CRISPR Industry Development Trends Analysis
- 2 CRISPR Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CRISPR Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CRISPR Market Analysis by Country
- 4.1 Global CRISPR Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global CRISPR Revenue Analysis by Country (2020-2025)
- 4.1.2 Global CRISPR Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.5 China CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.6 France CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.14 India CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand CRISPR Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa CRISPR Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global CRISPR Market Revenue by Key Suppliers (2021-2025)
- 5.2 CRISPR Competitive Landscape Analysis and Market Dynamic
- 5.2.1 CRISPR Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 CRISPR Market Analysis by Type
- 6.1 Global CRISPR Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global CRISPR Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Scientific CRISPR Product Portfolio
- 7.1.3 Thermo Fisher Scientific CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Merck KGaA
- 7.2.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merck KGaA CRISPR Product Portfolio
- 7.2.3 Merck KGaA CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 GenScript
- 7.3.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GenScript CRISPR Product Portfolio
- 7.3.3 GenScript CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Integrated DNA Technologies (IDT)
- 7.4.1 Integrated DNA Technologies (IDT) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Integrated DNA Technologies (IDT) CRISPR Product Portfolio
- 7.4.3 Integrated DNA Technologies (IDT) CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Horizon Discovery Group
- 7.5.1 Horizon Discovery Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Horizon Discovery Group CRISPR Product Portfolio
- 7.5.3 Horizon Discovery Group CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Agilent Technologies
- 7.6.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Agilent Technologies CRISPR Product Portfolio
- 7.6.3 Agilent Technologies CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Cellecta
- 7.7.1 Cellecta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Cellecta CRISPR Product Portfolio
- 7.7.3 Cellecta CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 GeneCopoeia
- 7.8.1 GeneCopoeia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 GeneCopoeia CRISPR Product Portfolio
- 7.8.3 GeneCopoeia CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Origene Technologies
- 7.9.1 Origene Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Origene Technologies CRISPR Product Portfolio
- 7.9.3 Origene Technologies CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 New England Biolabs
- 7.10.1 New England Biolabs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 New England Biolabs CRISPR Product Portfolio
- 7.10.3 New England Biolabs CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Synthego Corporation
- 7.11.1 Synthego Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Synthego Corporation CRISPR Product Portfolio
- 7.11.3 Synthego Corporation CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Toolgen
- 7.12.1 Toolgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Toolgen CRISPR Product Portfolio
- 7.12.3 Toolgen CRISPR Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 CRISPR Industry Chain Analysis
- 8.2 CRISPR Product Downstream Application Analysis
- 8.2.1 Global CRISPR Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global CRISPR Revenue and Forecast by Application (2020-2032)
- 8.3 CRISPR Typical Downstream Customers
- 8.4 CRISPR Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
